Related Experiment Video
Updated: Jul 20, 2026

06:31
Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Optimizing reproducibility for clinical studies involving patch testing and application of topical preparations
Juan P Jaimes1, An Liu, Sachin S Bhardwaj
1University of Minnesota, Minneapolis, MN 55455, USA.
Dermatitis : Contact, Atopic, Occupational, Drug
|September 8, 2006
Summary
Smaller syringes (0.5 mL and 1 mL) offer more reproducible petrolatum application for patch testing than larger 5 mL syringes. This improves consistency in controlled clinical trials.
Area of Science:
- Dermatology
- Clinical Trials
- Medical Device Technology
Background:
- Patch testing accuracy and consistency are crucial for reliable clinical trials.
- Current patch-test techniques present challenges in reproducibility.
- Standardizing material application is essential for valid study outcomes.
Purpose of the Study:
- To assess the accuracy and reproducibility of applying controlled petrolatum quantities using Finn Chambers.
- To compare the performance of different syringe sizes in delivering consistent petrolatum volumes.
- To identify optimal methods for standardized allergen application in patch testing.
Main Methods:
- Four dermatology nurses applied 240 samples of white petrolatum using 5 mL, 1 mL, and 0.5 mL syringes.
- Petrolatum amounts of 0.02 mL, 0.05 mL, and a "usual" amount were expressed onto Finn Chambers.
- Each condition was repeated five times on two separate days to evaluate reproducibility.
Main Results:
- No significant differences were found in the average weight of 0.05 mL petrolatum applied with any syringe size compared to the gold standard.
- Significant differences were observed in the application of 0.02 mL petrolatum between 5 mL and 0.5 mL syringes.
- Variability in measurements was significantly higher with the 5 mL syringe compared to smaller syringes, influenced by nurse and day.
Conclusions:
- Smaller syringes (0.5 mL and 1 mL) provide more consistent and reproducible petrolatum application than 5 mL syringes.
- Using smaller syringes enhances the reliability of controlled allergen dosing in patch testing.
- Standardization of syringe size can improve the quality of patch-test clinical trials.
More Related Videos
Related Concept Videos
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

